The merger provides a clear value creation path through substantial cost synergies and vertical integration. Traders should monitor regulatory developments (antitrust reviews in US, EU, and other jurisdictions) and shareholder vote timelines. The long close timeline (first half 2027) introduces execution risk; any delays or regulatory pushback could pressure the spread. Watch for potential competing bids given the strategic value of the combined assets.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 17 $12.73entry
- T+1 · 5mo ago −5.18%α −5.96% · $12.07
- T+5 · 5mo ago −11.08%α −10.03% · $11.32
- T+20 · 4mo ago −6.83%α −8.15% · $11.86
- T+60 · 2mo ago −25.06%α −28.21% · $9.54
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Huntsman and Olin announced a definitive all-stock merger of equals to create OlinHuntsman Corporation, a $12B+ North American chemicals leader. The deal provides Huntsman shareholders with 0.576 Olin shares per share, with Olin shareholders owning 54.5% and Huntsman shareholders 45.5% of the combined entity. Management identified over $400 million in cost synergies and expects the transaction to close in the first half of 2027, subject to regulatory and shareholder approvals.
Key Financial Metrics
Key Facts
- Huntsman shareholders receive 0.576 shares of Olin per Huntsman share; Olin shareholders own ~54.5%, Huntsman ~45.5% of combined company
- Combined company named OlinHuntsman Corporation, headquartered in The Woodlands, Texas
- Pro forma 2025 revenue of ~$12.5 billion and adjusted EBITDA of ~$1.3 billion including expected cost synergies
- Over $400 million in identified cost synergies: $300 million expected within 24 months of close, plus $100 million+ from raw material integration in 2031 as contracts expire
- Cost to achieve synergies estimated at $150 million to $200 million
- Additional ~$125 million in cash tax benefits from acceleration of tax NOLs (not included in synergy figure)
- Pro forma year-end 2025 net leverage of 4.6x, or ~3.2x with full synergy implementation; no bond maturities before 2029
- Peter Huntsman to serve as Non-Exec Chairman, Ken Lane as CEO, Phil Lister as CFO, Todd Slater as Chief Integration Officer
- Expected close in first half of 2027, subject to regulatory approvals and shareholder votes from both companies
Financial Impact
The merger creates a combined entity with pro forma 2025 revenue of ~$12.5 billion and adjusted EBITDA of ~$1.3 billion including synergies. Over $400 million in cost synergies identified, with $300 million achievable within 24 months. Additional $125 million in tax benefits from NOL acceleration. Pro forma net leverage of 4.6x (3.2x with synergies).
Risk Factors
- Regulatory approval risk: antitrust reviews in multiple jurisdictions could impose conditions or block the deal
- Shareholder approval risk: both Olin and Huntsman shareholders must approve; dissent could emerge on valuation or strategic fit
- Integration execution risk: achieving $400M+ synergies requires successful combination of operations, systems, and cultures
- Cyclical downturn in chemicals could pressure pro forma EBITDA and delay deleveraging
- Long timeline to close (first half 2027) exposes deal to macro and industry changes
- Termination fee not disclosed; no protection details available
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001104659-26-074630 |
| Document: 0001104659-26-074630-index-headers.html | 0001104659-26-074630 |
| Document: 0001104659-26-074630-index.html | 0001104659-26-074630 |
| Document: 0001104659-26-074630.txt | 0001104659-26-074630 |
Track record
29 reports on HUN
3 of 10 bullish or bearish reports moved the stock their way by T+1. Best: +4.19% at T+1 after the Nov 2, 2026 report. 4 of 10 went positive at some point.
Filters
- Nov 12, 20264d ago SC 13G/A Bearish 4/10 Entry $9.66 to $9.53 Now $9.30 +3.73% ▲ +1.35% +0.98% vs SPY
- Nov 11, 20265d ago Press Release Neutral 2/10 Entry $9.66 to $9.53 Now $9.30 −3.73% ▼ −1.35% −0.98% vs SPY
- Nov 2, 202614d ago 8-K Bullish 5/10 Entry $9.55 to $9.95 Now $9.30 −2.62% ▲ +4.19% +2.54% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $9.64 to $9.95 Now $9.30 −3.53% ▲ +3.22% +3.69% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $9.64 to $9.95 Now $9.30 −3.53% ▲ +3.22% +3.69% vs SPY
- Oct 6, 20265w ago 3 Neutral 2/10 Entry $8.63 to $8.50 Now $9.30 +7.76% ▼ −1.51% −1.08% vs SPY
- Aug 25, 202611w ago 8-K Bullish 6/10 Entry $9.63 to $9.65 Now $9.30 −3.43% ▲ +0.21% −0.45% vs SPY
- Aug 3, 202615w ago Insider Buy Bullish 4/10 Entry $10.43 to $10.14 Now $9.30 −10.83% ▼ −2.78% −2.58% vs SPY
- Jul 31, 202615w ago 425 Neutral 5/10 Entry $10.02 to $10.43 Now $9.30 −7.19% ▲ +4.09% +2.29% vs SPY
- Jul 31, 202615w ago 425 Neutral 5/10 Entry $10.02 to $10.43 Now $9.30 −7.19% ▲ +4.09% +2.29% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers